Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Swedberg

Showing results (51-60 of 218) with videos related to

Pageof 22
Sort By:
BMJ (Clinical Research Ed.)|April 3, 1993
ACE inhibitors after myocardial infarctionK Swedberg, J Kjekshus
British Heart Journal|September 1, 1994
Is neurohormonal activation a major determinant of the response to ACE inhibition in left ventricular dysfunction and heart failure?A Sigurdsson, K Swedberg
Evidence-Based Cardiovascular Medicine|December 29, 2005
2-year survival with atenolol administrationK Swedberg, H Wedel
Acta Medica Scandinavica|October 1, 1974
Heart failure as complication of lithium treatment. Preliminary report of a fatal caseK Swedberg, B Winblad
Journal of Cardiac Failure|December 1, 1996
The use of ACE inhibitors after myocardial infarctionK Swedberg, A Sigurdsson
The American Journal of Cardiology|July 11, 1988
Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)K Swedberg, J Kjekshus
American Heart Journal|July 1, 1996
The role of neurohormonal activation in chronic heart failure and postmyocardial infarctionA Sigurdsson, K Swedberg
Drugs|January 1, 1987
Haemodynamic effects of felodipine in congestive heart failureP Held, K Swedberg
Lancet (London, England)|June 10, 1998
Lack of efficacy of neutral endopeptidase inhibitor ecadotril in heart failure. The International Ecadotril Multi-centre Dose-ranging Study InvestigatorsJ G Cleland, K Swedberg
Annals of Neurology|October 1, 1981
Clinical and biochemical heterogeneity of globoid cell leukodystrophyD F Farrell, K Swedberg
Pageof 22

Showing results (51-60 of 218) with videos related to

Sort By:
Pageof 22
BMJ (Clinical Research Ed.)|April 3, 1993
ACE inhibitors after myocardial infarctionK Swedberg, J Kjekshus
British Heart Journal|September 1, 1994
Is neurohormonal activation a major determinant of the response to ACE inhibition in left ventricular dysfunction and heart failure?A Sigurdsson, K Swedberg
Evidence-Based Cardiovascular Medicine|December 29, 2005
2-year survival with atenolol administrationK Swedberg, H Wedel
Acta Medica Scandinavica|October 1, 1974
Heart failure as complication of lithium treatment. Preliminary report of a fatal caseK Swedberg, B Winblad
Journal of Cardiac Failure|December 1, 1996
The use of ACE inhibitors after myocardial infarctionK Swedberg, A Sigurdsson
The American Journal of Cardiology|July 11, 1988
Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)K Swedberg, J Kjekshus
American Heart Journal|July 1, 1996
The role of neurohormonal activation in chronic heart failure and postmyocardial infarctionA Sigurdsson, K Swedberg
Drugs|January 1, 1987
Haemodynamic effects of felodipine in congestive heart failureP Held, K Swedberg
Lancet (London, England)|June 10, 1998
Lack of efficacy of neutral endopeptidase inhibitor ecadotril in heart failure. The International Ecadotril Multi-centre Dose-ranging Study InvestigatorsJ G Cleland, K Swedberg
Annals of Neurology|October 1, 1981
Clinical and biochemical heterogeneity of globoid cell leukodystrophyD F Farrell, K Swedberg
Pageof 22